News
With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations ...
"This is a real concern for all patients who have been benefiting from this medicine. There will be panic and hysteria out ...
Thousands of overweight people are to be prescribed low-calorie soups and shakes on the NHS in a radical bid to tackle ...
It’s no secret that obesity is becoming an epidemic in the United States. It’s estimated that by 2030, 50 percent of ...
Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...
As the cost of Mounjaro jabs is set to increase by as much as 170 per cent, Jade Kay, who has already spent £2.4k on the drug ...
Eli Lilly & Co. raises Mounjaro prices in the United Kingdom to reduce costs in the U.S. Weight-loss drug prices increase by 170% in the U.K., but its National Health Service prices remained unchanged ...
The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...
Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.
Medical experts have warned Britons not to turn to fake weight loss jabs after fears the Mounjaro price hike could make it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results